Fabrication and characterization of lipopeptide biosurfactant-based electrospun nanofibers for use in tissue engineering.

Biosurfactant lipopeptidique Electrospinning Lipopeptide biosurfactan Nanofibers Nanofibres

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 16 04 2023
revised: 12 08 2023
accepted: 21 08 2023
pubmed: 27 8 2023
medline: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

Nanofibers are a class of nanomaterial with specific physicochemical properties and characteristics making them quite sought after and investigated by researchers. Lipopeptide biosurfactant (LPB) formulation properties were previously established in wound healing. LPB were isolated from in vitro culture of Acinetobacter junii B6 and loaded on nanofibers formulation produced by electrospinning method with different ratios of carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), and Poloxamer. Numerous experimental control tests were carried out on formulations, including physicochemical properties which were evaluated by using dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FT-IR), morphology study by scanning electron microscopy (SEM), and thermal stability. The best nanofibers formulation was obtained by the electrospinning method, with a voltage of 19.8 volts, a discharge capacity of 1cm/h, a cylindrical rotating velocity of 100rpm, and a needle interval of 7cm from the cylinder, which continued for 7hours. The formulation contained 2% (w/v) CMC, 10% (w/v) poloxamer, 9% (w/v) PVA, and 5% (w/v) LPB. This formula had desirable physicochemical properties including spreadability, stability, and uniformity with the particle size of about 590nm.

Identifiants

pubmed: 37633459
pii: S0003-4509(23)00102-5
doi: 10.1016/j.pharma.2023.08.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

968-976

Informations de copyright

Copyright © 2023 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Sepehr Afsharipour (S)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Samane Kavianipoor (S)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Mehdi Ranjbar (M)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Amir Mohammad Bagheri (AM)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Moslem Lari Najafi (M)

Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Ibrahim M Banat (IM)

Pharmaceutical Research Group, School of Biomedical Sciences, Ulster University, Coleraine BT51 1SA, N. Ireland, UK.

Mandana Ohadi (M)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: m.ohadi@kmu.ac.ir.

Gholamreza Dehghannoudeh (G)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: ghr_dehghan@kmu.ac.ir.

Classifications MeSH